✦ LIBER ✦

Timing of hormone therapy for prostate cancer

✍ Scribed by Baker, Holly

Book ID: 123473054
Publisher: The Lancet
Year: 2013
Tongue: English
Weight: 112 KB
Volume: 14
Category: Article
ISSN: 1470-2045
DOI: 10.1016/S1470-2045(13)70117-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The timing of hormone therapy for men wi

The timing of hormone therapy for men with asymptomatic advanced prostate cancer

✍ Edward Messing 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 125 KB

Determination of the time for maximal re

Determination of the time for maximal response to neoadjuvant hormone therapy for prostate cancer using magnetic resonance with spectroscopy (MRSI) and dynamic contrast enhancement (DCEMR)

✍ Sciarra, Alessandro; Panebianco, Valeria; Salciccia, Stefano; Lisi, Danilo; Alfa 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 727 KB

459 DETERMINATION OF THE TIME FOR MAXIMA

459 DETERMINATION OF THE TIME FOR MAXIMAL RESPONSE TO NEOADJUVANT HORMONE THERAPY (LEUPROLIDE) FOR PROSTATE CANCER USING MAGNETIC RESONANCE WITH SPECTROSCOPY (MRSI) AND DYNAMIC CONTRAST ENHANCEMENT (DCEMR)

✍ Sciarra, Alessandro; Panebianco, Valeria; Salciccia, Stefano; Gentilucci, Alessa 📂 Article 📅 2010 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 44 KB

Cost-effectiveness of the addition of ea

Cost-effectiveness of the addition of early hormonal therapy in locally advanced prostate cancer: results decisively determined by the cut-off time-point chosen for the analysis

✍ N Neymark; I Adriaenssen; T Gorlia; S Caleo; M Bolla; D Brochon 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Estimating survival gain for economic ev

Estimating survival gain for economic evaluations with survival time as principal endpoint: A cost-effectiveness analysis of adding early hormonal therapy to radiotherapy in patients with locally advanced prostate cancer

✍ N. Neymark; I. Adriaenssen; T. Gorlia; S. Caleo; M. Bolla 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB 👁 1 views

## Abstract The problem of estimating expected outcomes for the economic evaluation of treatments for which the outcome of principal interest is (quality adjusted) survival time has so far not received sufficient attention in the literature. The best estimate of expected survival is mean survival t

Timing hormonal therapy in prostate canc

Timing hormonal therapy in prostate cancer

✍ Sessions, Annette E; Messing, Edward M 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 54 KB